SCHEDULE 13G/A 0001178913-20-000735 0001376192 XXXXXXXX LIVE 5 Ordinary Shares, par value NIS 10.00 per share 06/30/2025 0000946394 Ellomay Capital Ltd M39927120 18 Rothschild Boulevard, 1st Floor Tel Aviv L3 6688112 Rule 13d-1(c) Clal Insurance Enterprises Holdings Ltd L3 1940045 1940045 1940045 N 14.58 CO With regard to Rows (6), (8) and (9), please see Item 4. Row (11) is based on 12,852,585 Ordinary Shares issued and outstanding as of June 30, 2025 (as reported by the Issuer in its Prospectus Supplement filed with the Securities and Exchange Commission on July 1, 2025). Ellomay Capital Ltd 18 Rothschild Boulevard, 1st Floor, Tel Aviv, Israel, 6688112 Clal Insurance Enterprises Holdings Ltd. ("Clal") 36 Raul Walenberg St., Tel Aviv 66180, Israel Israel Y Of the 1,940,045 Ordinary Shares reported in this Statement as beneficially owned by the Reporting Person, (i) 41,204 Ordinary Shares (which include 34,596 shares issuable upon exercise of warrants to purchase Ordinary Shares that are exercisable within 60 days) are beneficially held for its own account (the "Nostro Shares"); and (ii) 1,898,841 Ordinary Shares (which include 416,001 shares issuable upon exercise of warrants to purchase Ordinary Shares that are exercisable within 60 days) are held for members of the public through, among others, provident funds and/or pension funds and/or insurance policies, which are managed by subsidiaries of Clal, which subsidiaries operate under independent management and make independent voting and investment decisions. Consequently, this Statement shall not be construed as an admission by Clal, that it is the beneficial owner of more than the Nostro Shares. See Row (11) of the cover page of the Reporting Person above. See Row (6) of the cover page of the Reporting Person above and note in Item 4 above. See Row (8) of the cover page of the Reporting Person above and note in Item 4 above. Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Clal Insurance Enterprises Holdings Ltd /s/ Eran Czerninski 08/14/2025 /s/ Barak Benski 08/14/2025